Interobserver variability of the measurement of fetal nasal bone length between 11 + 0 and 13 + 6 gestation weeks among experienced and inexperienced sonographers

Ultraschall in der Medizin

Volumn 30, Issue 1, 2009, Pages 42-46

  Staboulidou, I ^a   Wustemann M ^a   Vaske, B ^a   Scharf, A ^b   Hillemanns, P ^a   Schmidt, P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

First trimester screening; Nasal bone; Quality control

Indexed keywords

ARTICLE; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FETUS; FETUS ECHOGRAPHY; FETUS NOSE BONE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GOOD LABORATORY PRACTICE; HUMAN; IMAGE ANALYSIS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVER VARIATION; RADIOLOGIST; SCREENING TEST;

ADOLESCENT; ADULT; CROWN-RUMP LENGTH; DOCUMENTATION; DOWN SYNDROME; FEMALE; HUMANS; NASAL BONE; OBSERVER VARIATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; REPRODUCIBILITY OF RESULTS; SKIN; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 63149163518     PISSN: 01724614     EISSN: 14388782     Source Type: Journal    
DOI: 10.1055/s-2008-1027402     Document Type: Article

References (18)

1. Snijders RJ, Noble P, Sebire N et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10 - 14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346
2. Spencer K, Souter V, Tul N et al. A screening program for trisomy 21 at 10 - 14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy associated plasma protein A. Ultrasound obstet gynecol 1999; 13: 231-237
3. Cicero S, Curcio P, Papageorghiou A et al. Absence of nasal bone in fetuses with trisomy 21 at 11 - 14 weeks of gestation: an observational study. Lancet 2001; 358: 1665-1667
4. Cicero S, Bindra R, Rembouskos G et al. Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11 - 14 weeks of gestation. J Matern Fetal Neonatal Med 2002; 11: 400-402
5. Orlandi F, Bilardo CM, Campogrande M et al. Measurement of the nasal bone length at 11 - 14 weeks of pregnancy and its potential role in Down syndrome risk assessment. Ultrasound Obstet Gynecol 2003; 22: 36-39
6. Cicero S, Rembouskos G, Vandecruys H et al. Likelihood ratio for trisomy 21 in fetus with absent nasal bone at the 11 - 14 week scan. Ultrasound Obstet Gynecol 2004; 23: 218-223
7. Malone FD, Ball RH, Nyberg DA et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 2004; 104: 1222-1228
8. Weingertner AS, Kohler M, Firtion C et al. Interest of foetal nasal bone measurement at first trimester Trisomy 21 screening. Fet Diagn Therap 2006; 21: 433-438
9. Ramos-Corpas D, Santiago JC, Montoya F. Ultrasonographic evaluation of fetal nasal bone in a low-risk population at 11 - 13 + 6 gestational weeks. Prenat Diagn 2006; 26: 112-117
10. Kozlowski P, Knippel AJ, Froehlich S et al. Additional performance of nasal bone in first trimester screening-nasal bone in first trimester screening. Ultraschall in Med 2006; 27: 336-339
11. Cicero S, Dezerega V, Andrade E et al. Learning curves for sonographic examination of the fetal nasal bone at 11 - 14 weeks. Ultrasound Obstet Gynecol 2003; 22: 135-137
12. Senat MV, Bernard JP, Boulvain M et al. Intra-and interobserver variability in fetal nasal bone assessment at 11 - 14 weeks of gestation. Ultrasound Obstet Gynecol 2003; 22: 138-141
13. Kanellopoulos V, Katsetos C, Economides DL. Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound Obstet Gynecol 2003; 22: 131-134
14. Braithwaite JM, Kadir RA, Pepera TA et al. Nuchal translucency measurement: training of potential examiners. Ultrasound Obstet Gynecol 1996; 8: 192-195
15. Merz E. The fetal nasal bone in the first trimester- precise assessment using 3D sonography. Ultraschall in Med 2005; 26: 365-366
16. Nicolaides KH, Spencer K, Avgidou K et al. Multicenter study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated twostage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226
17. Staboulidou I, Steinborn A, Schmidt P et al. Referenzwerte für das fetale Nasenbein im ersten Trimenon in einem Normalkollektiv. Z Geburth Neonatol 2006; 210: 173-178
18. Maymon R, Levinsohn-Tavor O, Cuckle H et al. Correlation between nasal bone length and nuchal translucency thickness. Prenat Diagn 2007; 27: 496-500